Neuro-Oncology: The Podcast

99 Episodes

1. Targeted therapy for BRAF-mutant pediatric glioma

   Published: 6/17/2022
2. Early/evolving IDH wild-type glioblastoma

   Published: 5/20/2022
3. PI3K signaling in IDH mutant gliomas

   Published: 5/6/2022
4. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

   Published: 4/22/2022
5. Molecular determinants of neurocognitive deficits in glioma

   Published: 4/8/2022
6. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

   Published: 3/25/2022
7. Clinical trial accrual for women and minorities in neuro-oncology

   Published: 3/11/2022
8. The clinical utility of next generation sequencing for IDHwt glioblastoma

   Published: 2/11/2022
9. Trabectedin for recurrent grade 2 or 3 meningiomas

   Published: 1/28/2022
10. Glioblastoma cell heterogeneity and plasticity

    Published: 1/14/2022
11. Moleculary integrated grading for meningioma

    Published: 12/24/2021
12. BOLD fMRI in IDH mutant gliomas

    Published: 12/10/2021
13. Glioblastoma subtypes and response to Dasatinib

    Published: 11/26/2021
14. Resection for recurrent brain metastases

    Published: 11/12/2021
15. Incidental Meningiomas

    Published: 10/29/2021
16. Immunosuppression in IDH mutant gliomas

    Published: 10/15/2021
17. Immunotherapy for melanoma brain metastases

    Published: 10/1/2021
18. DNA methylation profiles within the CATNON trial

    Published: 9/17/2021
19. 18F FET PET in childhood CNS tumors

    Published: 9/3/2021
20. Checkpoint blockade in atypical meningiomas

    Published: 8/20/2021